Letters in Drug Design & Discovery
Volume 16, 12 Issues, 2019
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
Contents
Letters in Drug Design & Discovery, Volume 1 - Number 3
Entry Inhibitors - A New Class of Aids Drugs
, 1(3): 184 - 193Marcus Vinicius Nora De Souza
DOI: 10.2174/1570180043398786
First Inhibitors of the Steroidogenic Enzyme Type 7 17β-Hydroxysteroid Dehydrogenase
, 1(3): 194 - 197E. Bellavance, V. Luu-The and D. Poirier
DOI: 10.2174/1570180043398867
Cytotoxicity of 5H-Dibenzo[c,h][1,6]naphthyridin-6-ones and 6H-Indeno[1,2-c]isoquinolin-5,11-diones in Tumor Cells Sensitive and Resistant to Camptothecin Analogs
, 1(3): 198 - 202Alexander L. Ruchelman, Sudhir K. Singh, Angela Liu, Nai Zhou, Leroy F. Liu and Edmond J. La Voie
DOI: 10.2174/1570180043399064
Peptide Based Vaccine Design for Cancer Immunotherapy
, 1(3): 203 - 210D. S. Pouniotis, J. Halton and V. Apostolopoulos
DOI: 10.2174/1570180043398894
Chemogenomic Investigation of AP-1 Transcriptional Regulation of LTC4 Synthase Expression
, 1(3): 211 - 216Tiana Chong, Michael McMillan, Jia Ling Teo, William R. Henderson Jr. and Michael Kahn
DOI: 10.2174/1570180043398920
Advanced Pharmacophore Model of Non-Competitive AMPA Antagonist 2,3-benzodiazepines
, 1(3): 217 - 223B. Rezessy and S. Solyom
DOI: 10.2174/1570180043398948
Armed Imidazo [1,2-a] Pyrimidines (Pyridines): Evaluation of Antibacterial Activity
, 1(3): 224 - 229A. Anaflous, N. Benchat, M. Mimouni, S. Abouricha, T. Ben-Hadda, B. El-Bali, A. Hakkou and B. Hacht
DOI: 10.2174/1570180043398885
Proteomics to Identify Novel Biomarkers and Therapeutic Targets in Cardiovascular Disease
, 1(3): 237 - 246Markus Kubicek, Silvia M. Sanz-Gonzalez, Francisco Verdeguer and Vicente Andres
DOI: 10.2174/1570180043398975
Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate
, 1(3): 247 - 255P. S. Cogan, C. R. Fowler, G. C. Post and T. H. Koch
DOI: 10.2174/1570180043399000
New Drug Design for Gene Therapy - Taking Advantage of Introns
, 1(3): 256 - 262Shi-Lung Lin and Shao-Yao Ying
DOI: 10.2174/1570180043398939
Apoptosis Signaling Pathways as Therapeutic Targets in Lung Injury
, 1(3): 263 - 268Kazuyoshi Kuwano, Naoki Hagimoto, Michihiro Yoshimi, Takashige Maeyama and Yoichi Nakanishi
DOI: 10.2174/1570180043398849
Atorvastatin Therapy Increases Monocyte / Macrophage Paraoxonase 2 Expression and Reduces Oxidative Stress in Hyprecholesterolemic Patients
, 1(3): 269 - 274Rosenblat Mira, Hayek Tony, Hussein Khetam and Michael Aviram
DOI: 10.2174/1570180043399046
A Stereospecific Route for the Preparation of Trans-Combretastatin Analogs: Synthesis and Cytotoxicity
, 1(3): 275 - 278Hari Pati, Zarmeen Taherbhai, Lori Forrest, Martha Wicks, Suzanna Bailey, Andrew Staples, Michelle Stewart, William Pennington, Jeffrey Harris and Moses Lee
DOI: 10.2174/1570180043398821
Prevention of Cell Damage in Ischaemic-Reperfusion: Mitochondrial Respiratory Chain as a Pharmacological Target
, 1(3): 279 - 284D. Morin, R. Zini, J. P. Tillement and A. Berdeaux
DOI: 10.2174/1570180043398803
Amide Mono Thioxylated Derivatives of MEN 10627
, 1(3): 285 - 288M. Altamura, G. Balacco, A. Giolitti, A. Guidi, R. Patacchini, A. R. Renzetti, A. Triolo and C. A. Maggi
DOI: 10.2174/1570180043398966
Rabies Vaccines: The Third Generation
, 1(3): 289 - 292T. Vanniasinkam and H. C. J. Ertl
DOI: 10.2174/1570180043398911
  |
Editor-in-Chief
George Perry
University of Texas
San Antonio, TX
USA
Biography
View Full Editorial Board
University of Texas
San Antonio, TX
USA
Biography
Biography of George Perry
George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist recognized in the field of Alzheimer's disease research particularly for his work in oxidative stress. Dr. Perry has studied at many universities and holds multiple degrees including a Bachelor of Arts degree in Zoology from the University of California Santa Barbara and a PhD in Marine Biology from the Scrippss Institution of Oceanography at San Diego. He is distinguished as one of the top Alzheimer’s disease researchers by Expertscape with over 1000 publications, more than 66,000 citations (H=129), one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is a Semmes Foundation Distinguished University Chair in Neurobiology and is an active participant in many other scientific associations. He is an elected member of the Academies of Sciences of Mexico, Portugal, and Spain. In addition, Perry is an Editor of numerous scientific journals including Journal of Alzheimer’s Disease which he founded in 1998. Today, Perry continues his love for research while working as Dean of the College of Sciences at The University of Texas at San Antonio.
About the Journal
For Authors
For Librarians & Readers
Journal History
Letters in Drug Design & Discovery was introduced in 2004 with the assistance of Dr. George Perry, who is the current Editor-in-Chief serving since 2004.
Webmaster Contact: info@benthamscience.net